176 related articles for article (PubMed ID: 34312454)
1. Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy.
Winther SA; Mannerla MM; Frimodt-Møller M; Persson F; Hansen TW; Lehto M; Hörkkö S; Blaut M; Forsblom C; Groop PH; Rossing P
Sci Rep; 2021 Jul; 11(1):15208. PubMed ID: 34312454
[TBL] [Abstract][Full Text] [Related]
2. Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes.
Lassenius MI; Fogarty CL; Blaut M; Haimila K; Riittinen L; Paju A; Kirveskari J; Järvelä J; Ahola AJ; Gordin D; Härma MA; Kumar A; Hamarneh SR; Hodin RA; Sorsa T; Tervahartiala T; Hörkkö S; Pussinen PJ; Forsblom C; Jauhiainen M; Taskinen MR; Groop PH; Lehto M;
J Intern Med; 2017 Jun; 281(6):586-600. PubMed ID: 28393441
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of lymphocyte count in autoimmune diabetic nephropathy.
Xiang Z; Liu W; Fu S; Hu J; Yang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1639-1649. PubMed ID: 38432854
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and inflammatory faecal markers in collagenous colitis.
Wildt S; Nordgaard-Lassen I; Bendtsen F; Rumessen JJ
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):567-74. PubMed ID: 17556903
[TBL] [Abstract][Full Text] [Related]
5. Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs.
Hang I; Heilmann RM; Grützner N; Suchodolski JS; Steiner JM; Atroshi F; Sankari S; Kettunen A; de Vos WM; Zentek J; Spillmann T
BMC Vet Res; 2013 Oct; 9():201. PubMed ID: 24107268
[TBL] [Abstract][Full Text] [Related]
6. Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children.
Dostal A; Baumgartner J; Riesen N; Chassard C; Smuts CM; Zimmermann MB; Lacroix C
Br J Nutr; 2014 Aug; 112(4):547-56. PubMed ID: 24916165
[TBL] [Abstract][Full Text] [Related]
7. Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity.
Igudesman D; Crandell JL; Corbin KD; Hooper J; Thomas JM; Bulik CM; Pence BW; Pratley RE; Kosorok MR; Maahs DM; Carroll IM; Mayer-Davis EJ
J Nutr; 2023 Apr; 153(4):1178-1188. PubMed ID: 36841667
[TBL] [Abstract][Full Text] [Related]
8. Chronic Psychosocial Stress and Gut Health in Children: Associations With Calprotectin and Fecal Short-Chain Fatty Acids.
Michels N; Van de Wiele T; De Henauw S
Psychosom Med; 2017 Oct; 79(8):927-935. PubMed ID: 27787408
[TBL] [Abstract][Full Text] [Related]
9. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
10. Associations between diet, the gut microbiome and short chain fatty acids in youth with islet autoimmunity and type 1 diabetes.
Harbison JE; Thomson RL; Wentworth JM; Louise J; Roth-Schulze A; Battersby RJ; Ngui KM; Penno MAS; Colman PG; Craig ME; Barry SC; Tran CD; Makrides M; Harrison LC; Couper JJ
Pediatr Diabetes; 2021 May; 22(3):425-433. PubMed ID: 33470492
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
Andréasson K; Ohlsson B; Mandl T
Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
[TBL] [Abstract][Full Text] [Related]
12. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F
Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764
[TBL] [Abstract][Full Text] [Related]
13. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients.
Saraheimo M; Teppo AM; Forsblom C; Fagerudd J; Groop PH
Diabetologia; 2003 Oct; 46(10):1402-7. PubMed ID: 12928771
[TBL] [Abstract][Full Text] [Related]
14. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy.
Gu T; Horová E; Möllsten A; Seman NA; Falhammar H; Prázný M; Brismar K; Gu HF
J Diabetes Complications; 2012; 26(5):393-8. PubMed ID: 22770937
[TBL] [Abstract][Full Text] [Related]
16. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey.
Hestvik E; Tumwine JK; Tylleskar T; Grahnquist L; Ndeezi G; Kaddu-Mulindwa DH; Aksnes L; Olafsdottir E
BMC Pediatr; 2011 Feb; 11():9. PubMed ID: 21284894
[TBL] [Abstract][Full Text] [Related]
17. Faecal calprotectin as a marker for oesophago-gastric cancer.
Vincent Z; Hornby S; Ball S; Sanders G; Ayling RM
Ann Clin Biochem; 2015 Nov; 52(Pt 6):660-4. PubMed ID: 25732128
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.
Zhulina Y; Cao Y; Amcoff K; Carlson M; Tysk C; Halfvarson J
Aliment Pharmacol Ther; 2016 Sep; 44(5):495-504. PubMed ID: 27402063
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with diabetic nephropathy in children, adolescents, and adults with type 1 diabetes.
Huang CY; Ting WH; Lo FS; Tsai JD; Sun FJ; Chan CI; Chiang YT; Lin CH; Cheng BW; Wu YL; Hung CM; Lee YJ
J Formos Med Assoc; 2017 Dec; 116(12):924-932. PubMed ID: 29070437
[TBL] [Abstract][Full Text] [Related]
20. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.
Suh JS; Kim SH; Cho KS; Jung IA; Cho WK; Jeon YJ; Jung MH; Suh BK
Pediatr Nephrol; 2016 Apr; 31(4):623-31. PubMed ID: 26525196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
